NCT06728111

Brief Summary

The aim of this study is to gain insight into the etiology of myocardial injury after non cardiac surgery. Furthermore, suspected etiologies were explored and hierarchically classified into most likely cause how this determines prognosis and what factors are associated with improved outcome.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,114

participants targeted

Target at P75+ for all trials

Timeline
10mo left

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jul 2023Mar 2027

Study Start

First participant enrolled

July 24, 2023

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

December 5, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Expected
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

1.6 years

First QC Date

December 5, 2024

Last Update Submit

December 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Main etiologies elevated troponin T

    The primary endpoint is a description of the main etiologies found within patients with an elevated troponin T after non cardiac surgery.

    from enrollment

Secondary Outcomes (1)

  • Differences in adjudication

    from enrollment

Interventions

The baseline population will consist of all patients who underwent a form of non-cardiac surgery. Baseline variables, medication use, type of surgery and perioperative hemodynamic and laboratory variables will be extracted from the hospital information system. One year mortality is registered, as well as major vascular events. This is in line with previous publications from our group. The adjudication strategy used for patients with myocardial injury. For the adjudication process minimal two senior anesthesiologists will be invited. Two members with at least one senior anesthesiologist will receive a sample of patients to adjudicate. Together the entire panel will adjudicate all patients. The goal to investigate the differences between the raters.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The population to be studied consists of all non-cardiac surgical patients who underwent surgery at Erasmus MC in the period 2017-2023.

You may qualify if:

  • Age \> 18 year of age
  • Undergoing non-cardiac surgery in the Erasmus MC, with (high-sensitive) Troponin T \> 50 ng/L measured in any of the first three days after surgery.

You may not qualify if:

  • Re-operations within the study period.
  • Daycare surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasmus Medical Center

Rotterdam, Netherlands

Location

Study Officials

  • Sanne Hoeks, PhD

    Epidemiologist

    STUDY DIRECTOR
  • Felix van Lier, PhD

    Anesthesiologist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

December 5, 2024

First Posted

December 11, 2024

Study Start

July 24, 2023

Primary Completion

March 1, 2025

Study Completion (Estimated)

March 1, 2027

Last Updated

December 11, 2024

Record last verified: 2024-12

Locations